Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Treatment. This report contains market size and forecasts of Gastrointestinal Cancer Treatment in global, including the following market information:
Global Gastrointestinal Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gastrointestinal Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global gastrointestinal cancer drugs market is driven by growth in prevalence of gastrointestinal cancer, increase in demand for targeted drug delivery, rise in public awareness, government initiatives to eliminate cancer, and patent expiry of key cancer drugs
We surveyed the Gastrointestinal Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gastrointestinal Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Global Gastrointestinal Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gastrointestinal Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Centers
Others
Global Gastrointestinal Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gastrointestinal Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gastrointestinal Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Cancer Treatment, market overview.
Chapter 2: Global Gastrointestinal Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Gastrointestinal Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Cancer Treatment Overall Market Size
2.1 Global Gastrointestinal Cancer Treatment Market Size: 2022 VS 2029
2.2 Global Gastrointestinal Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Cancer Treatment Players in Global Market
3.2 Top Global Gastrointestinal Cancer Treatment Companies Ranked by Revenue
3.3 Global Gastrointestinal Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gastrointestinal Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Cancer Treatment Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Targeted Drugs Therapy
4.1.4 Chemo Therapy
4.1.5 Adjuvant Chemotherapy
4.1.6 Radiation Therapy
4.2 By Type - Global Gastrointestinal Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Cancer Treatment Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Cancer Treatment Revenue, 2024-2029
4.2.3 By Type - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Cancer Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Centers
5.1.5 Others
5.2 By Application - Global Gastrointestinal Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Cancer Treatment Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Cancer Treatment Revenue, 2024-2029
5.2.3 By Application - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gastrointestinal Cancer Treatment Market Size, 2022 & 2029
6.2 By Region - Global Gastrointestinal Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Cancer Treatment Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Cancer Treatment Revenue, 2024-2029
6.2.3 By Region - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gastrointestinal Cancer Treatment Revenue, 2018-2029
6.3.2 US Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.3.3 Canada Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.3.4 Mexico Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Cancer Treatment Revenue, 2018-2029
6.4.2 Germany Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.3 France Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.4 U.K. Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.5 Italy Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.6 Russia Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.4.8 Benelux Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Cancer Treatment Revenue, 2018-2029
6.5.2 China Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.5.3 Japan Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.5.4 South Korea Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.5.6 India Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gastrointestinal Cancer Treatment Revenue, 2018-2029
6.6.2 Brazil Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.6.3 Argentina Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Cancer Treatment Revenue, 2018-2029
6.7.2 Turkey Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.7.3 Israel Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Gastrointestinal Cancer Treatment Market Size, 2018-2029
6.7.5 UAE Gastrointestinal Cancer Treatment Market Size, 2018-2029
7 Gastrointestinal Cancer Treatment Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Gastrointestinal Cancer Treatment Major Product Offerings
7.1.4 Eli Lilly Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 F. Hoffmann
7.2.1 F. Hoffmann Company Summary
7.2.2 F. Hoffmann Business Overview
7.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Major Product Offerings
7.2.4 F. Hoffmann Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Major Product Offerings
7.3.4 GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Gastrointestinal Cancer Treatment Major Product Offerings
7.4.4 Merck Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Gastrointestinal Cancer Treatment Major Product Offerings
7.5.4 Novartis AG Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Otsuka Holdings
7.6.1 Otsuka Holdings Company Summary
7.6.2 Otsuka Holdings Business Overview
7.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Major Product Offerings
7.6.4 Otsuka Holdings Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.6.5 Otsuka Holdings Key News & Latest Developments
7.7 Stryker Corporation
7.7.1 Stryker Corporation Company Summary
7.7.2 Stryker Corporation Business Overview
7.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Major Product Offerings
7.7.4 Stryker Corporation Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.7.5 Stryker Corporation Key News & Latest Developments
7.8 Boston Scientific Corporation
7.8.1 Boston Scientific Corporation Company Summary
7.8.2 Boston Scientific Corporation Business Overview
7.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Major Product Offerings
7.8.4 Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.8.5 Boston Scientific Corporation Key News & Latest Developments
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Company Summary
7.9.2 Johnson and Johnson Business Overview
7.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Major Product Offerings
7.9.4 Johnson and Johnson Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.9.5 Johnson and Johnson Key News & Latest Developments
7.10 CONMED Corporation
7.10.1 CONMED Corporation Company Summary
7.10.2 CONMED Corporation Business Overview
7.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Major Product Offerings
7.10.4 CONMED Corporation Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.10.5 CONMED Corporation Key News & Latest Developments
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Company Summary
7.11.2 Bristol-Myers Squibb Business Overview
7.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Major Product Offerings
7.11.4 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.11.5 Bristol-Myers Squibb Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Gastrointestinal Cancer Treatment Major Product Offerings
7.12.4 Pfizer Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.12.5 Pfizer Key News & Latest Developments
7.13 Celltrion Inc
7.13.1 Celltrion Inc Company Summary
7.13.2 Celltrion Inc Business Overview
7.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Major Product Offerings
7.13.4 Celltrion Inc Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.13.5 Celltrion Inc Key News & Latest Developments
7.14 Amgen Limited
7.14.1 Amgen Limited Company Summary
7.14.2 Amgen Limited Business Overview
7.14.3 Amgen Limited Gastrointestinal Cancer Treatment Major Product Offerings
7.14.4 Amgen Limited Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.14.5 Amgen Limited Key News & Latest Developments
7.15 Celgene Corporation
7.15.1 Celgene Corporation Company Summary
7.15.2 Celgene Corporation Business Overview
7.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Major Product Offerings
7.15.4 Celgene Corporation Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.15.5 Celgene Corporation Key News & Latest Developments
7.16 Sanofi
7.16.1 Sanofi Company Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Gastrointestinal Cancer Treatment Major Product Offerings
7.16.4 Sanofi Gastrointestinal Cancer Treatment Revenue in Global Market (2018-2023)
7.16.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gastrointestinal Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Cancer Treatment Market Drivers in Global Market
Table 3. Gastrointestinal Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Cancer Treatment in Global Market
Table 5. Top Gastrointestinal Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gastrointestinal Cancer Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gastrointestinal Cancer Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gastrointestinal Cancer Treatment Product Type
Table 9. List of Global Tier 1 Gastrointestinal Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gastrointestinal Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gastrointestinal Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gastrointestinal Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gastrointestinal Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gastrointestinal Cancer Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gastrointestinal Cancer Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Gastrointestinal Cancer Treatment Product Offerings
Table 32. Eli Lilly Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. F. Hoffmann Company Summary
Table 35. F. Hoffmann Gastrointestinal Cancer Treatment Product Offerings
Table 36. F. Hoffmann Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Gastrointestinal Cancer Treatment Product Offerings
Table 40. GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Gastrointestinal Cancer Treatment Product Offerings
Table 44. Merck Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Gastrointestinal Cancer Treatment Product Offerings
Table 48. Novartis AG Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Otsuka Holdings Company Summary
Table 51. Otsuka Holdings Gastrointestinal Cancer Treatment Product Offerings
Table 52. Otsuka Holdings Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Otsuka Holdings Key News & Latest Developments
Table 54. Stryker Corporation Company Summary
Table 55. Stryker Corporation Gastrointestinal Cancer Treatment Product Offerings
Table 56. Stryker Corporation Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Stryker Corporation Key News & Latest Developments
Table 58. Boston Scientific Corporation Company Summary
Table 59. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product Offerings
Table 60. Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Boston Scientific Corporation Key News & Latest Developments
Table 62. Johnson and Johnson Company Summary
Table 63. Johnson and Johnson Gastrointestinal Cancer Treatment Product Offerings
Table 64. Johnson and Johnson Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Johnson and Johnson Key News & Latest Developments
Table 66. CONMED Corporation Company Summary
Table 67. CONMED Corporation Gastrointestinal Cancer Treatment Product Offerings
Table 68. CONMED Corporation Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. CONMED Corporation Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product Offerings
Table 72. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Gastrointestinal Cancer Treatment Product Offerings
Table 76. Pfizer Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Celltrion Inc Company Summary
Table 79. Celltrion Inc Gastrointestinal Cancer Treatment Product Offerings
Table 80. Celltrion Inc Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Celltrion Inc Key News & Latest Developments
Table 82. Amgen Limited Company Summary
Table 83. Amgen Limited Gastrointestinal Cancer Treatment Product Offerings
Table 84. Amgen Limited Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Amgen Limited Key News & Latest Developments
Table 86. Celgene Corporation Company Summary
Table 87. Celgene Corporation Gastrointestinal Cancer Treatment Product Offerings
Table 88. Celgene Corporation Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Celgene Corporation Key News & Latest Developments
Table 90. Sanofi Company Summary
Table 91. Sanofi Gastrointestinal Cancer Treatment Product Offerings
Table 92. Sanofi Gastrointestinal Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 93. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Gastrointestinal Cancer Treatment Segment by Type in 2022
Figure 2. Gastrointestinal Cancer Treatment Segment by Application in 2022
Figure 3. Global Gastrointestinal Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Cancer Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastrointestinal Cancer Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 16. US Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 28. China Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gastrointestinal Cancer Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gastrointestinal Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Eli Lilly Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Otsuka Holdings Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Stryker Corporation Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Johnson and Johnson Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CONMED Corporation Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Pfizer Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Celltrion Inc Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Amgen Limited Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Celgene Corporation Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sanofi Gastrointestinal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
